Search details
1.
Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer.
N Engl J Med
; 386(5): 437-448, 2022 02 03.
Article
in English
| MEDLINE | ID: mdl-35045221
2.
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer.
N Engl J Med
; 386(6): 556-567, 2022 02 10.
Article
in English
| MEDLINE | ID: mdl-35139274
3.
Pertuzumab study in the neoadjuvant setting for HER2-positive nonmetastatic breast cancer in Australia (PeRSIA).
Int J Cancer
; 152(2): 267-275, 2023 01 15.
Article
in English
| MEDLINE | ID: mdl-36005450
4.
Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-expansion stage of a multicentre, open-label, phase I trial.
Br J Cancer
; 129(5): 797-810, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37474720
5.
Metastatic primary breast neuroendocrine neoplasms: a case series.
Intern Med J
; 53(10): 1813-1818, 2023 10.
Article
in English
| MEDLINE | ID: mdl-36314732
6.
Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer.
N Engl J Med
; 381(25): 2403-2415, 2019 12 19.
Article
in English
| MEDLINE | ID: mdl-31562800
7.
Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial.
Lancet Oncol
; 21(5): 699-709, 2020 05.
Article
in English
| MEDLINE | ID: mdl-32305099
8.
Taxane-induced peripheral neuropathy: differences in patient report and objective assessment.
Support Care Cancer
; 28(9): 4459-4466, 2020 Sep.
Article
in English
| MEDLINE | ID: mdl-31925531
9.
Timing flexibility of oral NEPA, netupitant-palonosetron combination, administration for the prevention of chemotherapy-induced nausea and vomiting (CINV).
Support Care Cancer
; 27(4): 1309-1317, 2019 Apr.
Article
in English
| MEDLINE | ID: mdl-30685793
10.
Evaluating the role of magnetic resonance imaging post-neoadjuvant therapy for breast cancer in the NEONAB trial.
Intern Med J
; 48(6): 699-705, 2018 06.
Article
in English
| MEDLINE | ID: mdl-28869790
11.
Optimal clinical assessment strategies for chemotherapy-induced peripheral neuropathy (CIPN): a systematic review and Delphi survey.
Support Care Cancer
; 25(11): 3485-3493, 2017 11.
Article
in English
| MEDLINE | ID: mdl-28589310
12.
Comparison of the clinical effectiveness of treatments for aromatase inhibitor-induced arthralgia in breast cancer patients: A systematic review with network meta-analysis.
Crit Rev Oncol Hematol
; 181: 103898, 2023 Jan.
Article
in English
| MEDLINE | ID: mdl-36535489
13.
Health-Related Quality of Life in Patients With Advanced Endometrial Cancer Treated With Lenvatinib Plus Pembrolizumab or Treatment of Physician's Choice.
Eur J Cancer
; 186: 172-184, 2023 06.
Article
in English
| MEDLINE | ID: mdl-37086595
14.
Lenvatinib Plus Pembrolizumab in Previously Treated Advanced Endometrial Cancer: Updated Efficacy and Safety From the Randomized Phase III Study 309/KEYNOTE-775.
J Clin Oncol
; 41(16): 2904-2910, 2023 06 01.
Article
in English
| MEDLINE | ID: mdl-37058687
15.
Breast Radiotherapy after Oncoplastic Surgery-A Multidisciplinary Approach.
Cancers (Basel)
; 14(7)2022 Mar 25.
Article
in English
| MEDLINE | ID: mdl-35406457
16.
Real-World Outcomes of Ribociclib and Aromatase Inhibitor Use in First Line Hormone Receptor Positive, HER2-Negative Metastatic Breast Cancer.
Clin Breast Cancer
; 22(8): 792-800, 2022 12.
Article
in English
| MEDLINE | ID: mdl-36151018
17.
Results of PD-L1 Analysis of Women Treated with Durvalumab in Advanced Endometrial Carcinoma (PHAEDRA).
Cancers (Basel)
; 15(1)2022 Dec 30.
Article
in English
| MEDLINE | ID: mdl-36612250
18.
Pembrolizumab as adjuvant therapy in a patient with Lynch syndrome with synchronous mixed clear cell carcinoma of ovarian origin and endometroid endometrial carcinoma.
BMJ Case Rep
; 14(11)2021 Nov 12.
Article
in English
| MEDLINE | ID: mdl-34772680
19.
Clinical activity of durvalumab for patients with advanced mismatch repair-deficient and repair-proficient endometrial cancer. A nonrandomized phase 2 clinical trial.
J Immunother Cancer
; 9(6)2021 06.
Article
in English
| MEDLINE | ID: mdl-34103352
20.
Electrophysiological and phenotypic profiles of taxane-induced neuropathy.
Clin Neurophysiol
; 131(8): 1979-1985, 2020 08.
Article
in English
| MEDLINE | ID: mdl-32291143